Drug reference
adrenochrome monosemicarbazone
Coagulant
Coagulant
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Indications
Reduce capillary fragilityControl oozing from raw surfacesPrevent microvessel bleeding (e.g., epistaxis, haematuria, secondary haemorrhage from wounds)
Dosing
- Adult
- 1–5 mg oral, i.m.
Related guidelines
GI bleeding on antiplatelet or anticoagulant therapy
CSI · Cardiology · 2020
Stroke and TIA — secondary prevention
AHA · Neurology · 2021
Abnormal uterine bleeding
FOGSI · Obstetrics & Gynaecology · 2016
Postpartum haemorrhage
FOGSI · Obstetrics & Gynaecology · 2024
Dyslipidaemia management
ICMR · Cardiology · 2023
Other Unclassified drugs
Ask House about adrenochrome monosemicarbazone
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team